These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25499773)

  • 1. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.
    Jones SP; Tang XL; Guo Y; Steenbergen C; Lefer DJ; Kukreja RC; Kong M; Li Q; Bhushan S; Zhu X; Du J; Nong Y; Stowers HL; Kondo K; Hunt GN; Goodchild TT; Orr A; Chang CC; Ockaili R; Salloum FN; Bolli R
    Circ Res; 2015 Feb; 116(4):572-86. PubMed ID: 25499773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.
    Lefer DJ; Bolli R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):332-9. PubMed ID: 21821536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAESAR: one step beyond in the construction of a translational bridge for cardioprotection.
    Fernández-Jiménez R; Ibanez B
    Circ Res; 2015 Feb; 116(4):554-6. PubMed ID: 25677511
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.
    Bøtker HE; Hausenloy D; Andreadou I; Antonucci S; Boengler K; Davidson SM; Deshwal S; Devaux Y; Di Lisa F; Di Sante M; Efentakis P; Femminò S; García-Dorado D; Giricz Z; Ibanez B; Iliodromitis E; Kaludercic N; Kleinbongard P; Neuhäuser M; Ovize M; Pagliaro P; Rahbek-Schmidt M; Ruiz-Meana M; Schlüter KD; Schulz R; Skyschally A; Wilder C; Yellon DM; Ferdinandy P; Heusch G
    Basic Res Cardiol; 2018 Aug; 113(5):39. PubMed ID: 30120595
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardioprotection: Where to from here?
    Kloner RA; Hale SL; Dai W; Shi J
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):53-61. PubMed ID: 27714476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition After Myocardial Infarction.
    Fernández-Jiménez R; Galán-Arriola C; Sánchez-González J; Agüero J; López-Martín GJ; Gomez-Talavera S; Garcia-Prieto J; Benn A; Molina-Iracheta A; Barreiro-Pérez M; Martin-García A; García-Lunar I; Pizarro G; Sanz J; Sánchez PL; Fuster V; Ibanez B
    Circ Res; 2017 Aug; 121(4):439-450. PubMed ID: 28596216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of femoral and aortic remote ischaemia preconditioning for cardioprotection against myocardial ischaemia/reperfusion injury in a rat model.
    Chai Q; Liu J; Hu Y
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1013-8. PubMed ID: 25205781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed postconditioning in the mouse heart in vivo.
    Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of xenon anesthesia on the size of experimental myocardial infarction.
    Baumert JH; Hein M; Gerets C; Baltus T; Hecker KE; Rossaint R
    Anesth Analg; 2007 Nov; 105(5):1200-6, table of contents. PubMed ID: 17959941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart.
    Charan K; Goyal A; Gupta JK; Yadav HN
    J Surg Res; 2016 Apr; 201(2):272-8. PubMed ID: 27020807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ischemic preconditioning and exogenous L-arginine reduce infarct size in rabbit heart].
    Ding YF; Li YL; Ho SY
    Sheng Li Xue Bao; 1996 Dec; 48(6):564-70. PubMed ID: 9389155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive limb ischemic preconditioning protects against myocardial I/R injury in rats.
    Li SJ; Wu YN; Kang Y; Yin YQ; Gao WZ; Liu YX; Lou JS
    J Surg Res; 2010 Nov; 164(1):162-8. PubMed ID: 19726056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous electrical nerve stimulation as a novel method of remote preconditioning: in vitro validation in an animal model and first human observations.
    Merlocco AC; Redington KL; Disenhouse T; Strantzas SC; Gladstone R; Wei C; Tropak MB; Manlhiot C; Li J; Redington AN
    Basic Res Cardiol; 2014 May; 109(3):406. PubMed ID: 24604614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial protection at a crossroads: the need for translation into clinical therapy.
    Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
    Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of limb and myocardial ischemia postconditioning with acute myocardial reperfusion injury].
    Zhang XH; Li CM; Ma XJ; Luo M
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):841-5. PubMed ID: 16681977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs.
    Vahlhaus C; Schulz R; Post H; Rose J; Heusch G
    J Mol Cell Cardiol; 1998 Feb; 30(2):197-209. PubMed ID: 9514996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.